Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,282.40
(
0.00%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.56
(
1.32%
)
Bitcoin
67,917.12
(
0.12%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 138094

Thursday, 05/03/2012 9:25:01 PM

Thursday, May 03, 2012 9:25:01 PM

Post# of 257269
EXAS said on today’s CC that they’re spending significant money to induce trial centers in the DEEP-C study (http://www.clinicaltrials.gov/ct2/show/NCT01397747 ) to enroll more patients age 65 and up, which struck me as curious. Have other biotech companies reported paying trial centers for such an inducement?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today